₹ 174
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Low dividends
Data is available to registered users only
Data is available to registered users only
About
Sanjivani Paranteral Ltd. is a pharmaceutical company that manufactures and supplies a variety of medical products. Its offerings include medications such as antibiotics, anti-emetics, anti-diabetics, and anti-fungals. The firm was established on October 5, 1994, by Anami H. Khemka, Ashwin A. Khemka, and Somesh Khemka, and its central operations are based in Mumbai, India.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT
Data is available to registered users only